Arcturus Therapeutics Holdings Inc ARCT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:10 PM EST
51.17quote price arrow down-0.26 (-0.51%)
Volume
462,741
52 week range
8.51 - 129.71

...

Loading . . .

KEY STATS

  • Open52.81
  • Day High53.91
  • Day Low48.80
  • Prev Close51.43
  • 52 Week High129.71
  • 52 Week High Date12/07/20
  • 52 Week Low8.51
  • 52 Week Low Date03/13/20
  • Market Cap1.345B
  • Shares Out26.28M
  • 10 Day Average Volume1.03M
  • Dividend-
  • Dividend Yield-
  • Beta2.77
  • 1 Year % Change263.94

RATIOS/PROFITABILITY

  • EPS (TTM)-3.23
  • P/E (TTM)-15.86
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-50.462M
  • ROE (MRQ)-34.98%
  • Revenue (MRQ)10.27M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-506.70%
  • Debt To Equity (MRQ)5.76%

EVENTS

  • Earnings Date03/01/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Arcturus Therapeutics Holdings Inc News

There is no recent news for this security.

Latest ARCT News From Our Partners

QUOTE FINDER

Profile

MORE
Arcturus Therapeutics Holdings Inc. is a clinical-stage messenger ribonucleic acid (mRNA) medicines and vaccines company. The Company’s technologies include LUNAR lipid-mediated delivery, STARR mRNA Technology and mRNA drug substance along with drug product manufacturing. Its pipeline of ribonucleic acid (RNA) therapeutic candidates include programs to treat ornithine transcarbamylase (OTC) deficiency, cystic fibrosis, glycogen storage disease type three, hepatitis B...
Peter Farrell Ph.D.
Chairman
Joseph Payne
President
Padmanabh Chivukula
Chief Operating Officer
Andrew Sassine
Chief Financial Officer
Address
10628 Science Center Dr Ste 250
San Diego, CA
92121-1132
United States